[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Reasons RGEN is Risky and 1 Stock to Buy Instead

3 Reasons RGEN is Risky and 1 Stock to Buy Instead

RGEN : 144.24 (+0.21%)
2 High-Flying Stocks on Our Watchlist and 1 We Find Risky

2 High-Flying Stocks on Our Watchlist and 1 We Find Risky

PLXS : 267.27 (-1.22%)
BELFA : 229.55 (+1.38%)
RGEN : 144.24 (+0.21%)
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

MO : 71.79 (+0.28%)
AMP : 506.76 (+1.32%)
RGEN : 144.24 (+0.21%)
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in...

RGEN : 144.24 (+0.21%)
3 Out-of-Favor Stocks We Keep Off Our Radar

3 Out-of-Favor Stocks We Keep Off Our Radar

ARHS : 7.86 (-0.51%)
INGR : 98.75 (+1.29%)
RGEN : 144.24 (+0.21%)
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of...

RGEN : 144.24 (+0.21%)
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks

Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks

RGEN : 144.24 (+0.21%)
Why Repligen (RGEN) Stock Is Trading Up Today

Why Repligen (RGEN) Stock Is Trading Up Today

RGEN : 144.24 (+0.21%)
1 Growth Stock with Explosive Upside and 2 Facing Headwinds

1 Growth Stock with Explosive Upside and 2 Facing Headwinds

PAR : 16.88 (+0.84%)
VEEV : 190.12 (+0.22%)
RGEN : 144.24 (+0.21%)
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

RGEN : 144.24 (+0.21%)
AHCO : 10.22 (+0.59%)
IQV : 207.85 (-0.54%)

Barchart Exclusives

Intel Future Price Hikes Send Huge Demand Signal to Wall Street
Intel is raising chip prices as server CPU demand outpaces supply, and Wall Street sees the move as proof of a much bigger AI-driven boom ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.